Announcements

Castle Biosciences Inc. Chief Commercial Officer Tobin W Juvenal filed a Form 4 on August 19, 2026, reporting the sale of 1,730 shares of common stock on August 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Director William Pate filed a Form 4 with the SEC on August 19, 2026, disclosing the sale of 89,500 shares of Par Pacific Holdings, Inc. common stock across four transactions on August 17 and August 18, 2026.

Nicola Deidre Petal Greenway, Chief Human Resources Officer of Takeda Pharmaceutical Co Ltd (NYSE:TAK), filed a Form 4 on August 19, 2026, reporting the sale of 12,980 American Depositary Shares on August 18, 2026.

Leslie A. Moriyama, Chief Financial Officer of Dorchester Minerals, L.P. (NASDAQ:DMLP), filed a Form 4 on August 19, 2026, disclosing the purchase of 5,197 common units on that same date.

Director Earl C. Shanks filed a Form 4 with the SEC on August 19, 2026, reporting the open-market purchase of 10,000 shares of Gaming & Leisure Properties, Inc. common stock on August 18, 2026.

Bryan Leach, CEO, President, and a Director of Ibotta, Inc., filed a Statement of Changes in Beneficial Ownership on August 19, 2026, reporting multiple transactions in Class A Common Stock conducted on August 17 and August 18, 2026, pursuant to a Rule 10b5-1 trading …

Teresa DeLuca, a director of Surgery Partners, Inc., filed a Form 4 on August 19, 2026, disclosing the open-market purchase of 10,000 shares of common stock on August 18, 2026.